The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

ישראלמגייס משתתפיםPHASE3

מצבים רפואיים

Sickle Cell Disease

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Investigational Site Number : 3760001, Afula, Israel

  • Investigational Site Number : 3760002, Afula, Israel

  • Investigational Site Number : 3760005, Haifa, Israel

  • Investigational Site Number : 3760006, Haifa, Israel

  • University of Alabama at Birmingham- Site Number : 8400003, Birmingham, Alabama, United States

  • Phoenix Children's Hospital- Site Number : 8400028, Phoenix, Arizona, United States

  • University of California San Francisco- Site Number : 8400040, Fresno, California, United States

  • Oncology & Hematology Associates of West Broward- Site Number : 8400029, Coral Springs, Florida, United States

  • Sylvester Comprehensive Cancer Center- Site Number : 8400020, Miami, Florida, United States

  • University of Illinois-Chicago - College of Medicine- Site Number : 8400054, Chicago, Illinois, United States

  • Indiana University Health Riley Hospital for Children- Site Number : 8400056, Indianapolis, Indiana, United States

  • Louisiana State University Health Sciences Center - Shreveport- Site Number : 8400037, Shreveport, Louisiana, United States

  • University of Maryland School of Medicine - Baltimore- Site Number : 8400041, Baltimore, Maryland, United States

  • University of Michigan Health System - Ann Arbor- Site Number : 8400035, Ann Arbor, Michigan, United States

  • Southern Specialty Research- Site Number : 8400059, Flowood, Mississippi, United States

  • Richmond University Medical Center- Site Number : 8400038, Staten Island, New York, United States

  • Montefiore Medical Center - Moses Campus- Site Number : 8400057, The Bronx, New York, United States

  • Prisma Health- Site Number : 8400051, Greenville, South Carolina, United States

  • Baylor College of Medicine- Site Number : 8400055, Houston, Texas, United States

  • VCU Massey Cancer Center: Dalton Oncology Clinic- Site Number : 8400012, Richmond, Virginia, United States

  • Investigational Site Number : 0560003, Brussels, Belgium

  • Investigational Site Number : 0560002, Brussels, Belgium

  • Investigational Site Number : 0560001, Leuven, Belgium

  • Hospital Santa Izabel- Site Number : 0760006, Salvador, Estado de Bahia, Brazil

  • Universidade Federal de Goias- Site Number : 0760002, Goiânia, Goiás, Brazil

  • Fundação Faculdade Regional de Medicina de São José do Rio Preto- Site Number : 0760001, São José do Rio Preto, São Paulo, Brazil

  • Pontifícia Universidade Católica do Rio de Janeiro- Site Number : 0760009, Rio de Janeiro, Brazil

  • Hospital Samaritano De Sao Paulo- Site Number : 0760005, São Paulo, Brazil

  • Investigational Site Number : 2500002, Créteil, France

  • Investigational Site Number : 2500005, Marseille, France

  • Investigational Site Number : 2500001, Paris, France

  • Investigational Site Number : 2500004, Toulouse, France

  • Investigational Site Number : 2760002, Essen, Germany

  • Investigational Site Number : 2760004, Stuttgart, Germany

  • Investigational Site Number : 3000001, Athens, Greece

  • Investigational Site Number : 3000003, Athens, Greece

  • Investigational Site Number : 3000002, Pátrai, Greece

  • Azienda Ospedaliero Universitaria Careggi SOD Ematologia-Site Number : 3800006, Florence, Firenze, Italy

    Contact: Study coordinator (Valentina Carrai) · carraiv@aou-careggi.toscana · 055 7949777
    Contact: Study coordinator (Silvia Querceto) · silvia.querceto@unifi.it · 055 7949777
    Contact: Principal Investigator (Valentina Carrai)
  • Investigational Site Number : 3800004, Milan, Milano, Italy

  • Azienda Ospedaliera Universitaria, Università della Campania "Luigi Vanvitelli" Napoli-Site Number : 3800005, Naples, Napoli, Italy

    Contact: Study coordinator (Silverio Perrotta) · silverio.perrotta@unicampania.it · +390815664185
    Contact: Study coordinator (Laura Pinfildi) · pinfildilaura@gmail.com · +390815664185
    Contact: Principal Investigator (Silverio Perrotta)
  • IRCCS Ospedale Pediatrico Bambino Gesù-Site Number : 3800001, Rome, Roma, Italy

    Contact: Study coordinator (Centro Trial Oncoematologico) · centrotrial-oncoematologico@opbg.net · +390668593697
    Contact: Principal Investigator (Franco Locatelli)
  • Azienda Ospedaliera Universitaria San Luigi Gonzaga, SSD Microcitemie Malattie Rare Ematologiche-Site Number : 3800007, Orbassano, Torino, Italy

    Contact: Study coordinator (Rosa Maria Catena De Maria) · rosamaria.demaria@unito.it · +393398110707
    Contact: Study coordinator (Vincenzo Voi) · vincenzo.voi@unito.it · +390119026852
    Contact: Principal Investigator (Vincenzo Voi)
  • Azienda Ospedaliera Ospedali Riuniti Villa Sofia - Cervello-Site Number : 3800002, Palermo, Italy

    Contact: Study coordinator (Rosario Di Maggio) · rdm83@hotmail.it · +390917802034
    Contact: Study coordinator (Alessandro Inzerillo) · aleinzerillo22@gmail.com · +393277653510
    Contact: Principal Investigator (Rosario Di Maggio)
  • Centro Ricerche Cliniche Verona s.r.l. presso Ospedale G.B. Rossi Borgo Roma-Site Number : 3800003, Verona, Italy

    Contact: Study coordinator (Lucia De Franceschi) · filippo.mazzi@aovr.veneto.it · +390458124918
    Contact: Principal Investigator (Lucia De Franceschi)
  • Investigational Site Number : 5280002, Rotterdam, Netherlands

  • Investigational Site Number : 5120001, Muscat, Oman

  • Investigational Site Number : 7240002, Madrid, Spain

  • Investigational Site Number : 7240001, Madrid, Spain

  • Investigational Site Number : 7920001, Adana, Turkey (Türkiye)

  • Investigational Site Number : 7920002, Adana, Turkey (Türkiye)

  • Investigational Site Number : 7920003, Mersin, Turkey (Türkiye)

  • Investigational Site Number : 8260002, London, Harrow, United Kingdom

  • Investigational Site Number : 8260001, London, London, City of, United Kingdom